← All stocks

Harmony Biosciences Holdings, Inc.

HRMY Net selling

CIK 0001802665 #1965 in the set updated 21 Sep 2026

Bought (120 mo)

$12.54M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$537.99M

$2.16M on a plan · $31.73M straight out of an exercise

Sold at will

$504.11M

104 of 186 sales

Net

−$525.45M

−$491.57M against sales at will

By person

13 insiders · 195 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Valor IV Pharma Holdings, LLC entity

10% owner

—

$139.39M (2)

−$139.39M

0.0000%

$0.00

—

Marshman Fund Trust II entity

10% owner

$8.15M (1)

$139.39M (2)

−$131.24M

6,051,120

10.39%

$260.53M

−3.7%

Wicki Andreas

Director

—

$127.30M (29)

−$127.30M

2,147,943

3.69%

$92.48M

−53.7%

Nielsen Jack

Director

$1.21M (6)

$96.52M (68)

−$95.31M

2,613,726

4.49%

$112.53M

−39.8%

Dierks Jeffrey

CHIEF COMMERCIAL OFFICER

—

$11.90M (38) scheduled

−$11.90M

0.0000%

$0.00

−100.0%

Jacobs John C

PRESIDENT, CEO

—

$8.78M (16) scheduled

−$8.78M

0.0000%

$0.00

—

Dayno Jeffrey M.

PRESIDENT, CEO

—

$5.43M (13) scheduled

−$5.43M

7,346

0.0126%

$316.28K

—

Kapadia Sandip

CHIEF FINANCIAL OFFICER

—

$3.89M (9) scheduled

−$3.89M

24,521

0.0421%

$1.06M

+2,452,000%

Novo Holdings A/S entity

10% owner

$3.18M (1)

—

+$3.18M

4,409,803

7.57%

$189.86M

—

Budur Kumar

CHIEF MEDICAL OFFICER

—

$3.11M (7) scheduled

−$3.11M

13,115

0.0225%

$564.66K

+1,205%

Serafin Andrew

CHIEF STRATEGY OFFICER

—

$2.29M (2) scheduled

−$2.29M

1,474

0.0025%

$63.46K

—

ARONIN JEFFREY S

Director

—

251,922

0.4326%

$10.85M

—

Zaeske Adam H.

CHIEF COMMERCIAL OFFICER

—

4,327

0.0074%

$186.30K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

ARONIN JEFFREY S

14 Dec 2021

Director

Exercised, kept

251,922

$24.00

$6.05M

Show all 195 transactions →

What was left out

Form 4 filings counted 182

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 8

Sales straight out of an exercise 74

Sales at will 104

Transactions with no price 0

Shares from compensation/vesting 28,755,795

Sales filed before the plan box existed 97

History held since 20 Aug 2020